Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

PLoS ONE
Multidisciplinary
2009English

Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

The Glasgow Prognostic Score at Diagnosis Is an Independent Predictor of Survival in Advanced Stage Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Prognostic Value of Pre-Transplant Pet/Ct in Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Pre-Treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma

Journal of Tumour Research & Reports
2018English

Outcome of Children and Adolescents With Lymphoblastic Lymphoma Treated With the Eortc 58951 Protocol

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy